{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:01:18Z","timestamp":1791486078395,"version":"4.3.4"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/cad.0000000000000098","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T17:48:48Z","timestamp":1395078528000},"page":"704-716","source":"Crossref","is-referenced-by-count":29,"title":["Enhanced noscapine delivery using estrogen-receptor-targeted nanoparticles for breast cancer therapy"],"prefix":"10.1097","volume":"25","author":[{"given":"Jitender","family":"Madan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushma R.","family":"Gundala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoganjaneyulu","family":"Kasetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad V.","family":"Bharatam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Aneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Katyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upendra K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210203","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2174\/138920012803762756","article-title":"Implications of nanoscale based drug delivery systems in delivery and targeting tubulin binding agent.","volume":"13","author":"Chandra","year":"2012","journal-title":"Curr Drug Metab"},{"key":"R2-11-20210203","first-page":"4749","article-title":"Polymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin.","volume":"7","author":"Liu","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"R3-11-20210203","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00614306","article-title":"Excretion of noscapine in human breast milk.","volume":"30","author":"Olsson","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"R4-11-20210203","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00280-007-0430-y","article-title":"Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.","volume":"60","author":"Aneja","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"R6-11-20210203","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.nano.2012.10.003","article-title":"Poly(ethylene)-glycol conjugated solid lipid nanoparticles of noscapine improve biological half-life, brain delivery and efficacy in glioblastoma cells.","volume":"9","author":"Madan","year":"2013","journal-title":"Nanomedicine"},{"key":"R8-11-20210203","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/CAD.0b013e32834159b8","article-title":"Long-circulating poly(ethylene glycol)-grafted gelatin nanoparticles customized for intracellular delivery of noscapine: preparation, in-vitro characterization, structure elucidation, pharmacokinetics, and cytotoxicity analyses.","volume":"22","author":"Madan","year":"2011","journal-title":"Anticancer Drugs"},{"key":"R9-11-20210203","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/10731199.2010.494578","article-title":"Advances in novel drug delivery strategies for breast cancer therapy.","volume":"38","author":"Dhankhar","year":"2010","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"key":"R10-11-20210203","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1210\/me.2004-0390","article-title":"Integration of the extranuclear and nuclear actions of estrogen.","volume":"19","author":"Levin","year":"2005","journal-title":"Mol Endocrinol"},{"key":"R11-11-20210203","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ijc.2910540119","article-title":"Estrone sulfate promotes human breast cancer cell replication and nuclear uptake of estradiol in MCF-7 cell cultures.","volume":"54","author":"Santner","year":"1993","journal-title":"Int J Cancer"},{"key":"R12-11-20210203","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0960-0760(00)00077-7","article-title":"Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors.","volume":"73","author":"Billich","year":"2000","journal-title":"J Steroid Biochem Mol Biol"},{"key":"R13-11-20210203","first-page":"5441","article-title":"Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis, and microtubule assembly in human breast cancer cells.","volume":"60","author":"MacCarthy-Morrogh","year":"2000","journal-title":"Cancer Res"},{"key":"R14-11-20210203","first-page":"226","article-title":"Synthesis and antiproliferative activity of a novel N-acyl derivative of doxorubicin.","volume":"25","author":"Shcherbakov","year":"1999","journal-title":"Bioorg Khim"},{"key":"R15-11-20210203","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v29.i5.20","article-title":"Targeted breast cancer nanotherapeutics: options and opportunities with estrogen receptors.","volume":"29","author":"Paliwal","year":"2012","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"R17-11-20210203","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/156800910791190210","article-title":"A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.","volume":"10","author":"Paliwal","year":"2010","journal-title":"Curr Cancer Drug Targets"},{"key":"R19-11-20210203","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.aca.2003.10.026","article-title":"Development of a solid-phase extraction-enzyme linked immunosorbent assay method for the determination of estrone in water.","volume":"503","author":"Li","year":"2004","journal-title":"Anal Chim Acta"},{"key":"R20-11-20210203","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.steroids.2005.10.006","article-title":"A direct antigen heterologous enzyme immunoassay for measuring progesterone in serum without using displacer.","volume":"71","author":"Basu","year":"2006","journal-title":"Steroids"},{"key":"R21-11-20210203","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj1240581","article-title":"The measurement of amino groups in proteins and peptides.","volume":"124","author":"Fields","year":"1971","journal-title":"Biochem J"},{"key":"R23-11-20210203","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/1389201053642349","article-title":"Release kinetics from bio-polymeric nanoparticles encapsulating protein synthesis inhibitor, cycloheximide, for possible therapeutic application.","volume":"6","author":"Verma","year":"2005","journal-title":"Curr Pharm Biotechnol"},{"key":"R24-11-20210203","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jconrel.2005.11.001","article-title":"Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design.","volume":"110","author":"Bhavsar","year":"2006","journal-title":"J Control Release"},{"key":"R25-11-20210203","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1021\/ja00299a024","article-title":"Development and use of quantum mechanics molecular models. 76. AM1: a new general purpose quantum mechanical molecular model.","volume":"107","author":"Dewar","year":"1985","journal-title":"J Am Chem Soc"},{"key":"R26-11-20210203","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/jps.2600760211","article-title":"Quantitation of the release of doxorubicin from colloidal dosage forms using dynamic dialysis.","volume":"76","author":"Gupta","year":"1987","journal-title":"J Pharm Sci"},{"key":"R27-11-20210203","first-page":"242","article-title":"The targeting of drugs parenterally by use of microspheres.","volume":"36","author":"Illum","year":"1982","journal-title":"J Parenter Sci Technol"},{"key":"R29-11-20210203","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.","volume":"65","author":"Mosmann","year":"1983","journal-title":"J Immunol Methods"},{"key":"R30-11-20210203","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1023\/A:1020404615898","article-title":"Uptake of FITC-chitosan nanoparticles by A549 cells.","volume":"19","author":"Huang","year":"2002","journal-title":"Pharm Res"},{"key":"R31-11-20210203","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug delivery in cancer.","volume":"14","author":"Cho","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R33-11-20210203","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1021\/jp9716997","article-title":"Quantum calculation of molecular energies and energy gradients in solution by a conductor solvent model.","volume":"102","author":"Barone","year":"1998","journal-title":"J Phys Chem A"},{"key":"R34-11-20210203","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jcc.10189","article-title":"Energies, structures, and electronic properties of molecules in solution with the C-PCM solvation model.","volume":"24","author":"Cossi","year":"2003","journal-title":"J Comput Chem"},{"key":"R35-11-20210203","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/carcin\/18.2.251","article-title":"Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines.","volume":"18","author":"Kang","year":"1997","journal-title":"Carcinogenesis"},{"key":"R36-11-20210203","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jbm.b.30092","article-title":"Prolonged cytotoxic effect of colchicine released from biodegradable microspheres.","volume":"71","author":"Muvaffak","year":"2004","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"R37-11-20210203","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jconrel.2003.11.006","article-title":"Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organization of human fibroblasts.","volume":"95","author":"Gupta","year":"2004","journal-title":"J Control Release"},{"key":"R38-11-20210203","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0939-6411(03)00187-5","article-title":"Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use.","volume":"57","author":"Vandervoort","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"R39-11-20210203","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijbiomac.2005.03.012","article-title":"Microscopic structure of gelatin coacervates.","volume":"36","author":"Mohanty","year":"2005","journal-title":"Int J Biol Macromol"},{"key":"R40-11-20210203","first-page":"1194","article-title":"Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer.","volume":"56","author":"Gerweck","year":"1996","journal-title":"Cancer Res"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0000000000000098","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:01:54Z","timestamp":1620946914000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201407000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0000000000000098","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}